Pharmacoepidemiology in Japan: Medical databases and research achievements

Journal of Pharmaceutical Health Care and Sciences

Volumn 1, Issue 1, 2015, Pages

  Tanaka, Shiro ^a   Seto, Kahori ^a   Kawakami, Koji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cost effectiveness; Medical database; Pharmacoepidemiology

Indexed keywords

ANTIRHEUMATIC AGENT; BIOLOGICAL PRODUCT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PALIVIZUMAB; PRAVASTATIN;

BRONCHITIS; CARDIOVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG DATABASE; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; ECZEMA; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; JAPAN; LOWER RESPIRATORY TRACT INFECTION; MEDICAL RECORD; MEDICAL RESEARCH; PHARMACOEPIDEMIOLOGY; PHASE 4 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; RISK MANAGEMENT;

EID: 85020120996     PISSN: None     EISSN: 20550294     Source Type: Journal    
DOI: 10.1186/s40780-015-0016-5     Document Type: Review

References (21)

1. Porta M. A Dictionary of Epidemiology. 5th ed. New York, NY: Oxford University Press; 2008.
2. Kita F, Shibata Y, Yorifuji T, Nakahata T, Kawakami J, Kawakami K. Prescription trends for treatment of paediatric gastroenteritis at a Japanese hospital between 1997 and 2007. J Clin Pharm Ther. 2010;35:87-92.
3. Urushihara H, Kawakami K. Development Safety Update Reports and Proposals for Effective and Efficient Risk Communication. Drug Saf. 2010;33:341-52.
4. Hahn OM, Schilsky RL. Randomized controlled trials and comparative effectiveness research. J Clinical Oncol. 2012;30:4194-201.
5. Yasmina A, Deneer VH, der Zee AH M-v, van Staa TP, de Boer A, Klungel OH. Application of routine electronic health record databases for pharmacogenetic research. J Intern Med. 2014;275:590-604.
6. Silverman SL. From randomized controlled trials to observational studies. Am J Med. 2009;122:114-20.
7. WHO: The UPPSALA MONITERING CENTER. Available at http://www.who-umc.org/DynPage.aspx?id=115092&mnl=7347&mn2=7252&mn3=7613&mn4=7614 , accessed March 27, 2015
8. Ministry of Health, Labour and Welfare: "Iryou Service no Shitsu no Koujou tou no tameno Reseputo Jouhou tou no Katsuyou ni kansuru Kentoukai" Houkokusho. Available at http://www.mhlw.go.jp/shingi/2008/01/dl/s0130-16a.pdf , accessed March 27, 2015
9. Ministry of Health, Labour and Welfare: "Denshika sareta Iryou Jouhou Database no Katsuyou niyoru Iyakuhin tou no Anzen Anshin ni kansuru teigen (Nihon no Sentinel Project) nitsuite". Available at http://www.mhlw.go.jp/stf/shingi/2r9852000000mlub.html , accessed March 27, 2015
10. Murakami A, Hirata Y, Motomura N, Miyata H, Iwanaka T, Takamoto S. The national clinical database as an initiative for quality improvement in Japan. Korean J of Thorac Cardiovasc Surg. 2014;47:437-43.
11. Kimura S, Sato T, Ikeda S, Noda M, Nakayama T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010;20:413-9.
12. Katada H, Yukawa N, Urushihara H, Tanaka S, Mimori T, Kawakami K. Prescription patterns and trends in anti-rheumatic drug use based on a large-scale claims database in Japan. Clin Rheumatol 2014. doi: 10.1007/s10067-013-2482-1
13. Hashikata H, Harada KH, Kagimura T, Nakamura M, Koizumi A. Usefulness of a large automated health records database in pharmacoepidemiology. Environ Health Prev Med. 2011;16:313-9.
14. Takahashi Y, Nishida Y, Asai S. Utilization of health care databases for pharmacoepidemiology. Eur J Clin Pharmacol. 2012;68:123-9.
15. Inoue D, Kishimoto H. Management of Glucocorticoid-induced or Lifestyle-related Disease-associated Osteoporosis in University Hospitals in Japan. J New Rem Clin. 2014;63:1292-301.
16. Hall GC, Sauer B, Bourke A, Brown JS, Revnolds MW, Lo Casale R. Guidelines for good database selection and use in pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2012;21:1-10.
17. Ministry of Education, Culture, Sports, Science and Technology and Ministry of Health, Labour and Welfare: The Ethical Guidelines on Biomedical Research Involving Human Subjects. Available at http://www.lifescience.mext.go.jp/files/pdf/n1443_01.pdf , Accessed March 27, 2015.
18. Ueyama H, Hinotsu S, Tanaka S, Urushihara H, Nakamura M, Nakamura Y, et al. Application of a self-controlled case series study to a database study in children. Drug Saf. 2014;37:259-68.
19. Luce BR, Drummond M, Jonsson B, Neumann PJ, Schwartz JS, Siebert U, et al. EBM, HTA, and CER: clearing the confusion. Milbank Q. 2010;88:256-76.
20. Onishi Y, Hinotsu S, Nakao YM, Urushihara H, Kawakami K. Economic evaluation of pravastatin for primary prevention of coronary artery disease based on risk prediction from JALS-ECC in Japan. Value Health Regional Issues. 2013;2:5-12.
21. Pharmaceuticals and Medical Devices Agency: Iryou Jouhou no Database tou wo motiita Iyakuhinn no Annzenseihyouka niokeru Yakuzaiekigakukennkyu no Jisshi ni kannsuru Guideline. Available at http://www.pmda.go.jp/files/000157340.pdf , Accessed March 27, 2015.